Robert F. Kennedy Jr., who's nominated to become the next health secretary, asked the federal government to revoke its ...
First and foremost, Habre recommends staying indoors as much as possible and keeping your windows closed. While the air may ...
First and foremost, Habre recommends staying indoors as much as possible and keeping your windows closed. While the air may ...
By not only trapping smoke and viruses, but destroying them too, these could be some of the most effective masks you can buy ...
Almost exactly 10 years after the FDA’s initial FDA approval for Bristol Myers Squibb’s Opdivo as the first PD-1 inhibitor in the U.S., the agency has cleared an under-the-skin version of the ...
Subcutaneous nivolumab and hyaluronidase-nvhy is FDA-approved for adult solid tumors, offering a new administration route for PD-1 inhibitors. The phase 3 CheckMate-67T trial confirmed ...
The FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new small molecules, biologics and oligonucleotide therapeutics last year. The class of 2024 was a little smaller than that ...
On December 25th Xinhua, the state-run news agency, reported that China had approved plans to build the world’s largest hydroelectric dam on the lower reaches of the Yarlung Tsangpo, which flows ...
Neffy for severe allergic reactions and Dupixent for chronic obstructive pulmonary disease (COPD), which all gained FDA approval this year. These medications are "slated to make a big clinical ...
The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity.
Rush University Medical Center, in a note on its website, said visitors and staff must wear hospital-approved masks in some areas, citing increased levels of COVID-19 and other respiratory ...
NEW DELHI: In a major step forward in the fight against HIV/AIDS, the US Food and Drug Administration (FDA) has approved Lenacapavir, an injectable HIV drug. This drug protects people for six ...